BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

831 related articles for article (PubMed ID: 26649414)

  • 1. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
    Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
    Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
    Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
    Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
    J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Hoenigl M; Prattes J; Spiess B; Wagner J; Prueller F; Raggam RB; Posch V; Duettmann W; Hoenigl K; Wölfler A; Koidl C; Buzina W; Reinwald M; Thornton CR; Krause R; Buchheidt D
    J Clin Microbiol; 2014 Jun; 52(6):2039-45. PubMed ID: 24671798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
    Danpornprasert P; Foongladda S; Tscheikuna J
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic role of polymerase chain reaction in bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in immunocompromised patients - A retrospective cohort study.
    Hardak E; Fuchs E; Leskes H; Geffen Y; Zuckerman T; Oren I
    Int J Infect Dis; 2019 Jun; 83():20-25. PubMed ID: 30926540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.
    Musher B; Fredricks D; Leisenring W; Balajee SA; Smith C; Marr KA
    J Clin Microbiol; 2004 Dec; 42(12):5517-22. PubMed ID: 15583275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchoalveolar galactomannan in invasive pulmonary aspergillosis: a prospective study in pediatric patients.
    Mohammadi S; Khalilzadeh S; Goudarzipour K; Hassanzad M; Mahdaviani A; Aarabi N; Pourabdollah M; Sigari N
    Med Mycol; 2015 Sep; 53(7):709-16. PubMed ID: 26229150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan.
    de Mol M; de Jongste JC; van Westreenen M; Merkus PJ; de Vries AH; Hop WC; Warris A; Janssens HM
    Pediatr Pulmonol; 2013 Aug; 48(8):789-96. PubMed ID: 22949309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.
    Johnson GL; Sarker SJ; Nannini F; Ferrini A; Taylor E; Lass-Flörl C; Mutschlechner W; Bustin SA; Agrawal SG
    J Clin Microbiol; 2015 Jul; 53(7):2103-8. PubMed ID: 25903568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis.
    Francesconi A; Kasai M; Petraitiene R; Petraitis V; Kelaher AM; Schaufele R; Hope WW; Shea YR; Bacher J; Walsh TJ
    J Clin Microbiol; 2006 Jul; 44(7):2475-80. PubMed ID: 16825367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.
    Boch T; Buchheidt D; Spiess B; Miethke T; Hofmann WK; Reinwald M
    Mycoses; 2016 Feb; 59(2):80-5. PubMed ID: 26627577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
    Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients.
    Mikulska M; Furfaro E; Dettori S; Giacobbe DR; Magnasco L; Dentone C; Ball L; Russo C; Taramasso L; Vena A; Angelucci E; Pelosi P; Bassetti M
    Mycoses; 2022 Apr; 65(4):411-418. PubMed ID: 35138675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Real-Time PCR and Platelia Galactomannan Assay for the Diagnosis of Invasive Pulmonary Aspergillosis: Bronchoalveolar Lavage Fluid Performs Better Than Serum in Non-neutropaenic Patients.
    Zhang S; Wang S; Wan Z; Que C; Li R; Yu J
    Mycopathologia; 2016 Oct; 181(9-10):625-9. PubMed ID: 27270570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Park SY; Lee SO; Choi SH; Sung H; Kim MN; Choi CM; Hong SB; Oh YM; Shim TS; Koh Y; Kim YS; Woo JH; Kim SH
    J Infect; 2010 Dec; 61(6):492-8. PubMed ID: 20833201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review.
    Avni T; Levy I; Sprecher H; Yahav D; Leibovici L; Paul M
    J Clin Microbiol; 2012 Nov; 50(11):3652-8. PubMed ID: 22952268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study.
    He H; Ding L; Sun B; Li F; Zhan Q
    Crit Care; 2012 Jul; 16(4):R138. PubMed ID: 22835335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients.
    Eigl S; Prattes J; Lackner M; Willinger B; Spiess B; Reinwald M; Selitsch B; Meilinger M; Neumeister P; Reischies F; Wölfler A; Raggam RB; Flick H; Eschertzhuber S; Krause R; Buchheidt D; Thornton CR; Lass-Flörl C; Hoenigl M
    Crit Care; 2015 Apr; 19(1):178. PubMed ID: 25927915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.